Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies

EJNMMI Research

Table 1 Characteristics of NICM patients

	All patients (n = 29)
Clinical characteristics
Male/female	12/17
Age (years)	43.14 ± 16.94
cTnI (pg/ml)	128.63 ± 168.39
CK (U/L)	106.83 ± 125.79
CK-MB (μg/L)	2.77 ± 2.99
NT-proBNP (pg/ml)	1819.36 ± 2660.61
Disease duration (months)	41.00 ± 35.00
Baseline echocardiographic parameters
LVEDD (mm)	60.79 ± 10.78
LVESD (mm)	47.69 ± 12.45
LVEF (%)	42.93 ± 14.66
⁶⁸Ga-FAPI-04 uptake
SUV_max	4.16 ± 2.75
SUV_mean	2.09 ± 1.31
SUVR	1.92 ± 1.18
LVMV (mL)	196.13 ± 64.93

Values are mean ± SD for continuous variables. cTnI Cardiac troponin I; CK Creatine kinase; CK-MB Creatine kinase-MB; NT-proBNP N-terminal fragment of pro-hormone brain natriuretic peptide; LA Left atrium; LVEDD Left ventricular end diastolic diameter; LVESD Left ventricular end systolic diameter; LVEF Left ventricular ejection fraction; SUV Standardized uptake value; LVMV Left ventricular metabolism volume